Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results

GlobeNewswireFeb 25 08:00 ET

BOCOM INTL: There is significant room for recovery in the mainland pharmaceutical Sector, and the foreign investment environment is expected to improve.

Subsequent bullish policies for finance and medical insurance/commercial insurance are expected to continue to be introduced, and the overall valuation of the sector remains at a historical low, indicating significant room for recovery in the sector, thus giving the mainland pharmaceutical Industry a "leading" rating.

Zhitong FinanceFeb 24 21:05 ET

Legend Biotech (NASDAQ:LEGN) Is Using Debt Safely

Simply Wall StFeb 24 05:00 ET

Market Concerns Put Pressure on Legend Biotech Corporation (LEGN) Shares

Yahoo FinanceFeb 21 09:43 ET

Express News | Legend Biotech Corp : TD Cowen Cuts Target Price to $62 From $67

ReutersFeb 21 06:56 ET

Express News | DeepSeek announces open sourcing of five projects next week.

Moomoo 24/7Feb 21 01:07 ET